SLAB » Topics » Fair Value of Financial Instruments

These excerpts taken from the SLAB 10-K filed Feb 11, 2009.

Fair Value of Financial Instruments

        The Company's financial instruments are recorded at amounts that reflect the Company's estimate of their fair values. SFAS 157, Fair Value Measurement, provides a hierarchal disclosure framework

F-7



Silicon Laboratories Inc.
Notes to Consolidated Financial Statements (Continued)
January 3, 2009

2. Significant Accounting Policies (Continued)


associated with the level of subjectivity used in measuring assets and liabilities at fair value. The three levels defined by the SFAS 157 hierarchy are as follows:

    Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

    Level 2—Inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

    Level 3—Inputs are unobservable for the asset or liability and are developed based on the best information available in the circumstances, which might include the Company's own data.

Fair Value of Financial Instruments



        The Company's financial instruments are recorded at amounts that reflect the Company's estimate of their fair values. SFAS 157, Fair Value Measurement,
provides a hierarchal disclosure framework



F-7










Silicon Laboratories Inc.

Notes to Consolidated Financial Statements (Continued)

January 3, 2009



2. Significant Accounting Policies (Continued)






associated
with the level of subjectivity used in measuring assets and liabilities at fair value. The three levels defined by the SFAS 157 hierarchy are as follows:





    Level 1—Inputs
    are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.



    Level 2—Inputs
    are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.



    Level 3—Inputs
    are unobservable for the asset or liability and are developed based on the best information available in the circumstances, which might include the Company's own
    data.





These excerpts taken from the SLAB 10-K filed Feb 7, 2008.

Fair Value of Financial Instruments

        The Company's financial instruments consist principally of cash and cash equivalents, short-term investments, accounts receivable and accounts payable. The Company believes all of these financial instruments are recorded at amounts that approximate their current market values.

F-7



Silicon Laboratories Inc.
Notes to Consolidated Financial Statements (Continued)
December 29, 2007

2. Significant Accounting Policies (Continued)

Fair Value of Financial Instruments



        The Company's financial instruments consist principally of cash and cash equivalents, short-term investments, accounts receivable and accounts
payable. The Company believes all of these financial instruments are recorded at amounts that approximate their current market values.



F-7








NAME="fk17401_silicon_laboratories_inc._note__sil03382">


Silicon Laboratories Inc.
Notes to Consolidated Financial Statements (Continued)
December 29, 2007



2. Significant Accounting Policies (Continued)




This excerpt taken from the SLAB 10-K filed Feb 7, 2007.

Fair Value of Financial Instruments

The Company’s financial instruments consist principally of cash and cash equivalents, short-term investments, accounts receivable and accounts payable. The Company believes all of these financial instruments are recorded at amounts that approximate their current market values.

This excerpt taken from the SLAB 10-K filed Apr 24, 2006.

FAIR VALUE OF FINANCIAL INSTRUMENTS

The Company’s financial instruments consist principally of cash and cash equivalents, short-term investments, receivables and accounts payable. The Company believes all of these financial instruments are recorded at amounts that approximate their current market values.

This excerpt taken from the SLAB 10-K filed Feb 9, 2006.
FAIR VALUE OF FINANCIAL INSTRUMENTS

The Company’s financial instruments consist principally of cash and cash equivalents, short-term investments, receivables and accounts payable. The Company believes all of these financial instruments are recorded at amounts that approximate their current market values.

F-8




2.   SIGNIFICANT ACCOUNTING POLICIES (Continued)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki